Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model
- PMID: 21073257
- DOI: 10.3171/2010.10.JNS10866
Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model
Abstract
Object: The optimal CSF Mg(++) concentration for vasodilation of spastic cerebral arteries after subarachnoid hemorrhage (SAH) and its duration are unknown. The temporal profile of the vasodilatory effect and optimal CSF Mg(++) concentration after the intracisternal injection of MgSO(4) solution were investigated in an SAH model in canines.
Methods: Cerebral vasospasm was induced by experimental SAH using a 2-hemorrhage model in 26 female beagles. On Day 7, 0.5 ml/kg of 15, 10, 5, or 0 mmol/L MgSO(4) in Ringer solution was injected into the cerebellomedullary cistern. Angiography was performed on Day 1 (before SAH) and before and 1, 3, and 6 hours after the intracisternal injection on Day 7 to measure arterial diameters of the basilar artery (BA), superior cerebellar artery (SCA), and vertebral artery (VA). Cerebrospinal fluid Mg(++) was also measured at the same time.
Results: Arterial diameters of the BA, SCA, and VA were significantly decreased by vasospasm on Day 7. Arterial diameter ratios (ratio of arterial diameter after MgSO(4) injection to diameter before injection on Day 7) of the BA and SCA at 1 and 3 hours after and the VA at 1 hour after intracisternal injection of the MgSO(4) solution were positively correlated with the CSF Mg(++) concentration. All arterial diameter ratios, except 1 point of the SCA, exceeded 1 if the CSF Mg(++) concentration was > 3 mEq/L at 1 hour after injection. Animals with CSF Mg(++) concentrations > 3 mEq/L at 1 hour after injection (11 dogs) showed significantly increased arterial diameters of the BA at 1 and 3 hours after and of the SCA and VA at 1, 3, and 6 hours after injection, as compared with the diameters before injection. The CSF Mg(++) concentration significantly increased at 1 hour (3.73 ± 0.69 mEq/L, p < 0.01) and 3 hours (2.05 ± 0.35 mEq/L, p < 0.01) after the intracisternal injection as compared with the baseline value (1.41 ± 0.20 mEq/L).
Conclusions: The reversible effect of an intracisternal injection of MgSO(4) solution on the spastic artery requires CSF Mg(++) concentrations > 3 mEq/L. The vasodilatory effect continues for 3-6 hours after injection. These results suggest that the continuous infusion or intermittent intracisternal injection of MgSO(4) is needed to maintain the optimal CSF Mg(++) concentration and constantly ameliorate cerebral vasospasm.
Similar articles
-
Double cisterna magna blood injection model of experimental subarachnoid hemorrhage in dogs.Transl Stroke Res. 2014 Dec;5(6):647-52. doi: 10.1007/s12975-014-0356-8. Epub 2014 Jul 3. Transl Stroke Res. 2014. PMID: 24986149 Review.
-
Effect of intrathecal magnesium sulfate solution injection via a microcatheter in the cisterna magna on cerebral vasospasm in the canine subarachnoid haemorrhage model.Br J Neurosurg. 2012 Feb;26(1):64-8. doi: 10.3109/02688697.2011.591948. Epub 2011 Jul 18. Br J Neurosurg. 2012. PMID: 21767131
-
Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage.J Neurosurg. 2009 Jan;110(1):73-8. doi: 10.3171/2008.4.17494. J Neurosurg. 2009. PMID: 18834261
-
Temporal profile of the effects of intracisternal injection of magnesium sulfate solution on vasodilation of spastic cerebral arteries in the canine SAH model.Acta Neurochir Suppl. 2011;110(Pt 2):39-42. doi: 10.1007/978-3-7091-0356-2_8. Acta Neurochir Suppl. 2011. PMID: 21125443
-
[Development of drug delivery system for intrathecal administration and its therapeutic effect on cerebral vasospasm and ischemia].Yakugaku Zasshi. 2004 Aug;124(8):541-7. doi: 10.1248/yakushi.124.541. Yakugaku Zasshi. 2004. PMID: 15297723 Review. Japanese.
Cited by
-
Controversies and evolving new mechanisms in subarachnoid hemorrhage.Prog Neurobiol. 2014 Apr;115:64-91. doi: 10.1016/j.pneurobio.2013.09.002. Epub 2013 Sep 25. Prog Neurobiol. 2014. PMID: 24076160 Free PMC article.
-
The role of magnesium in the management of cerebral vasospasm.Neurol Res Int. 2013;2013:943914. doi: 10.1155/2013/943914. Epub 2013 May 21. Neurol Res Int. 2013. PMID: 23766903 Free PMC article.
-
Magnesium lithospermate B, an active extract of Salvia miltiorrhiza, mediates sGC/cGMP/PKG translocation in experimental vasospasm.Biomed Res Int. 2014;2014:272101. doi: 10.1155/2014/272101. Epub 2014 Apr 2. Biomed Res Int. 2014. PMID: 24804208 Free PMC article.
-
Potential risk of artificial cerebrospinal fluid solution without magnesium ion for cerebral irrigation and perfusion in neurosurgical practice.Neurol Med Chir (Tokyo). 2013;53(9):596-600. doi: 10.2176/nmc.oa2012-0295. Neurol Med Chir (Tokyo). 2013. PMID: 24067770 Free PMC article.
-
Double cisterna magna blood injection model of experimental subarachnoid hemorrhage in dogs.Transl Stroke Res. 2014 Dec;5(6):647-52. doi: 10.1007/s12975-014-0356-8. Epub 2014 Jul 3. Transl Stroke Res. 2014. PMID: 24986149 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources